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The humt immunodeficiency virus (HIV) is aretrovirus that infects cells of the hu-
man immune system, destroys and impairs their function. In the early stagae of infection,
the person has no symptoms. However, as the infection $progress\propto$ , the immune sys-
tem becomae weaker, and the person becomae more susceptible to so-called opportunistic
infections. The most advanced stage of HIV infection is acquired immunodeflciency syn-
drome (AIDS). It can take 10-15 years on average for an HIV infected person to develop
AIDS. But some HIV infected patients are still asymptomatic after fifteen or more yeaoe
of infection but some patients develop AIDS within two years.
This variation in the rate of disease progression is poorly understood and is caused
by several factors such as viral reproductive abilitiae and immune proliferative abilitiae.
An elegant explanation of this question was propoeed by Martin A. Nowak in the early
$1990s$ . He pointed out the possible importance of viral diversity due to high HIV mu-
tation rate and created the viral diversity threshold theory. Rom the thraehold theory
proposed by Nowak downward, there is no study which can explain the questions about
the asymptomatic phase.
Here we discuss on immune impairment effect of HIV to propose anew explanation
for avariable lengh of the asymptomatic phase. We focus on adysfunction of dendritic
cells (DCs), which are crucial in the generation of adaptive immunity, caused by HIV
infection. Several studies found that some $DC$ populations are susceptible to HIV and
amodulation of $DCs$ by HIV infection leads to interference of their antigen $pr\infty enting$
function. This impliae that HIV disables DC’s ability which may be relevrt for optimal
induction of HIV specific immune responses. It is also reported that HIV infected individ-
uals have asignificant drrease in the number of $DCs$ compared with uninfected donors.
Adecreased number of $DC$ was shown in late-stage patients, $\bm{t}d$ more rrently loss of
DC was described in patients with high viral loads or in those with AIDS that develop
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opportunistic infection or cancer. These imply that a progression of HIV infection reflects
loss of DCs, which would in turn impair generation of antiviral CTLs. Therefore we can
consider the disease progression as increasing of immune impairment rate.
Let an increasing function $\epsilon(t)$ be a measure of impairment rate caused by a progres-
sive decrease of DC abundance. Interestingly, we can obtain the impairment thresholds
over an increase of $\epsilon$ ; “Risky threshold” $(\overline{\epsilon})$ and “Immunodeficiency threshold” $(\epsilon)$ . The
$D.isease$ progression
Figure 1: Four representative patterns of disease progression: In terms of our theorey,
we can conclude that a length of the asymptomatic phase is determined stochastically
by the host and viral states between $\overline{\epsilon}$ and $\epsilon^{*}$ . We use a simple mathematical model:
$x’=\lambda-dx-\beta xy,$ $y’=\beta xy-ay-pyz,$ $z’=cxyz/(1+\epsilon(t)y+\xi)-bz$ where $x,$ $y$
and $z$ represent uninfected CD4 $T$ cells, infected CD4 $T$ cells and CTLs, respectivelity.
Stochasticity can occur as a perturbation in the CTL proliferation $cxyz/(1+\epsilon(t)y+\xi)$ ,
where $\xi$ is a white noise measured by a normal distribution with mean $\mu$ and variance
$\sigma$ . Variance is fixed at $\sigma=0.05$ in the process. Each path (red, blue, orange, green) is
obtained as a sample of the process with mean $\mu=0.05$ (red), $\mu=0.03$ (blue), $\mu=0.0$
(orange) and $\mu=-0.01$ (green). Positive mean value implies that purturbations are
deleterious to the CTL proliferation on average. The white noise is incorporated with
a different time scale; for every $t=$ 10k $(k=0,1,2, \cdots)$ , the value of $\xi$ is updated.
We assume that impairment on DCs accumulates with a very low rate during disease
progression, $\epsilon(t)=10^{-4}t$ , where $10^{-4}$ is the rate of average impairment at which DCs are
gradually impaired by HIV during infection.
former implies that immune system may collapse when the impairment rate of HIV ex-
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ceeds the threshold value. The latter implies that immune system always collapses when
the lmpairment rate exceeds the value. The increase of impairment rate, which represents
aprogression of the infection, boosts the probability of adevelopment of immunodefi-
ciency under some perturbations. Actually, in the lnfected individual, there are many
perturbations which change the host and viral state during the course of HIV infection.
For example, it is known that amutation rate of HIV is higher than other virusae, the
mutant virus can escape from the current immune pressures and also HIV populations
switch their coreceptor from CCR5 to CXCR4 (which is more replicative than CCR5
virus) over the course of infection. These mutational events lead to some temporal in-
crease of the virus load $\bm{t}d$ decrease of immune raeponses. Further the emergence of
drug $r\infty istance$ , the chtge of $\dot{a}$ntiviral drug, the withdrawal of antiviral therapy and the
infection of other virus also lead to some temporal chtgae in the infected individual.
In terms of our theorey, we can conclude that alengh of the asymptomatic phase is
determined stochastically by the host $\cdot and$ viral stat\’e between $\overline{\epsilon}$ and $\epsilon$ (see Fig.1). The
patients are usually robust for th\’ee perturbations because the HIV infrted cells are al-
ways suppraesed by CTLs if the disease progr\’esion do\’e not exceed the risky thraehold
$(0<\epsilon<\overline{\epsilon})$ . However, when the HIV infection progresses exceeding the risky thr\’ehold
$(\overline{\epsilon}<\epsilon)$ , the patients become sensitive to these stochastic perturbations. The $mo8t$ severe
patients develop AIDS just $\mathfrak{R}er\epsilon$ becomes larger tht $\overline{\epsilon}$;lower numbers of $CD4^{+}T$ oells
and CTLs caused by stochastic events raeult in immunodeficiency (red in Fig.1). While
the moet mild patients do not develop AIDS until the infection prograesae excaeding the
immunodeficiency thraehold; viral load is well supproesed to low level by \’etablished CTL
$respons\infty$ with higher numbers of $CD4^{+}T$ cells and CTLs (green in Fig.1). Thus the
patients develop AIDS between $\overline{\epsilon}$ and $\epsilon$ .
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